Collectively, these data demonstrate increased NK-cell activation and DC frequency and activation in the lymph nodes accompanied by increased frequency, proliferation, and activation of CD8+ T cells in both the lymph nodes and the tumor following treatment with TAK-676. This evidence concerns the gene CD8A and neoplasm.